Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on August 19, 2025

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black …

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced that Chris …

New PXM Manifesto Demonstrates Urgency of Leading in the Age of Agentic AI
BOSTON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Salsify, the leading Product Experience Management (PXM) platform, today announced the publication of "The PXM AI Manifesto," a no-nonsense guide for digital commerce leaders. The manifesto cuts through the AI hype …

Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
SPC-15’s intranasal spray formulation meets safety standards for clinical trial development SARASOTA, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and …

iBio Announces Pricing of $50 Million Public Offering
SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase 71,540, …

SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its Board of Directors as an Independent Director and Chair of the …

Versori Unveils One-Click Catalogue Integration, Achieves 98% Accuracy for Marketplace Product Mapping
Versori’s One-Click Catalogue Sync lets retailers transfer products between marketplaces with 98% accuracy, saving time and eliminating data mismatches. MANCHESTER, UNITED KINGDOM, August 19, 2025 /EINPresswire.com/ -- Versori, a leader in Al-powered …

Fasoo Delivers CAD File Security Built for Semiconductor Supply Chain Collaboration
SEOUL, SOUTH KOREA, August 19, 2025 /EINPresswire.com/ -- Fasoo, the leader in data-centric security, today announced growing adoption of its file-centric collaboration and protection solutions in the semiconductor industry. In today’s competitive …

Interact Launches New Features to Expand Its Industry-Leading Employee Experience Platform
MANCHESTER, United Kingdom and NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Interact, the provider of the Employee Experience (EX) Platform that powers the world’s best workplaces, today announced a significant expansion of its platform capabilities with a …

Gaxos Labs Launches Art-Gen, an AI Image and Video Creation Platform Targeting Multi-Billion Dollar Market
Roseland, NJ, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Art-Gen.AI, an AI image and video …

Arvo Partners with UKG to Help SMBs Capture Tax Credits
COLUMBUS, Ohio, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arvo, the financial operations hub purpose-built for small businesses, today announced a technology partnership with UKG, a leading provider of HR, payroll, workforce management, and culture solutions. This …

Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
BOSTON and ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension (“PAH”), …

zSpace Empowers Educators with zKnow™: AI-Powered Assistant Delivers Instant Answers, Saving Teachers Valuable Time
SAN JOSE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a leader in immersive augmented reality (AR) solutions for education, today announced zKnowTM, an intelligent AI assistant that instantly answers educator questions about …

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
AUSTIN, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, …

Epiq and IRIS Partner to Deliver AI Document Capture and Management
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Epiq today announced a strategic partnership with IRIS, a Canon company, to transform how organizations convert documents into actionable knowledge and business insights. IRIS brings advanced AI and machine …

AdOmni Supercharges Ads Platform, Launching AI-Driven Self-Serve Campaigns in Minutes
LAS VEGAS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- AdOmni, the leading AI-powered programmatic Digital-Out-of-Home (DOOH) and video advertising platform, today announced groundbreaking enhancements to its platform that enables self-service DOOH campaigns to be …

Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
NEW YORK and CAMBRIDGE, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation Janus Kinase (JAK) inhibitors for patients with myeloproliferative neoplasms, today announced the appointment …

COUR Pharma Doses First Patient in Clinical Trial Evaluating CNP-103 in People Recently Diagnosed with Type 1 Diabetes
CHICAGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies to treat autoimmune diseases, today announced that the first patient has been dosed in the Phase 1b/2a …

Introducing VSCO Workspace for Professional Photographers
SAN FRANCISCO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- VSCO, the Visual Supply Company and a leading photography platform and creative community, today unveiled VSCO Workspace, a powerful studio management platform with customizable automations and tools …

Milestone® Pharmaceuticals to Present at Upcoming Conferences
MONTREAL and CHARLOTTE, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced President and CEO, Joe Oliveto, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference, to take place …